New research presented at the American Society for Pharmacology and Experimental Therapeutics annual meeting has demonstrated the potential for genetically engineered bacteria to be an effective ...

L-DOPA is the best drug we have for Parkinson’s disease, but its molecular mirror image, D-DOPA, causes dangerous side effects. Making L-DOPA without also making D-DOPA is surprisingly hard and ...

In the vast majority of cases of Parkinson’s disease, or “shaking palsy,” physicians cannot be sure what originally caused the nerve damage that results in the patient’s tremor, muscle rigidity, ...

BERLIN — Patients with restless legs syndrome (RLS) for whom conventional therapies are contraindicated may benefit from a treatment usually reserved for patients with advanced Parkinson's disease and ...

Researchers at the University of Georgia are developing a new treatment for Parkinson's that aleviates the motor symptoms of the disease without the complications of dosage fluctuations that create ...

Researchers think they know more about why levodopa, the first-line therapy for treating the motor symptoms of Parkinson disease (PD), loses efficacy and causes dyskinesia, or off periods, the longer ...

Philadelphia (April 1, 2022) – Researchers have engineered probiotic bacteria that can synthesize the dopamine precursor L-DOPA, a powerful mainstay treatment for Parkinson’s disease. Preclinical ...

WASHINGTON, June 17, 2024 — L-DOPA is the best drug we have for Parkinson’s disease, but its molecular mirror image, D-DOPA, causes dangerous side effects. Making L-DOPA without also making D-DOPA is ...